Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVB, PRP, and Combination Therapy for PDR
NCT04800679Phase 2Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2020
- Primary completion
- Jul 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in proliferative diabetic retinopathy (PDR), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT04800679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04800679.